Your browser doesn't support javascript.
loading
Home Use of Mechanical Insufflation/Exsufflation in Adult Patients in Western Switzerland.
Mitropoulou, Georgia; Heinzer, Raphael; Janssens, Jean-Paul; von Garnier, Christophe; Prella, Maura.
Afiliación
  • Mitropoulou G; Division of Pulmonology, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Heinzer R; Division of Pulmonology, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Janssens JP; Center for Investigation and Research in Sleep, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • von Garnier C; Division of Pulmonary Diseases, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Prella M; Division of Pulmonology, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Respiration ; 102(5): 341-350, 2023.
Article en En | MEDLINE | ID: mdl-36724753
ABSTRACT

BACKGROUND:

Mechanical insufflation/exsufflation (MI-E) devices are often prescribed to patients with inefficient cough and recurrent infections, but their use in the home setting is not well characterized.

OBJECTIVE:

The objective of this study was to report a real-life experience and identify factors that are associated with home MI-E use in adult patients.

METHODS:

This is a cross-sectional observational study of adult subjects with neurological disease using MI-E at home for more than 3 months.

RESULTS:

A total of 43 patients were included. Median age (interquartile range) was 48 (31-64) years. The most common diagnosis was muscular dystrophy (n = 15), followed by multiple sclerosis (n = 7) and amyotrophic lateral sclerosis (n = 7). 24 subjects (56%) reported using the MI-E at least once weekly. Based on device data downloads, the median objective use was 23% of days analysed (approximately 2 times per week). The vast majority (94%) of all participants reported using the device at least daily during an infectious episode, while 62% reported having used the device in emergency situations such as bronchoaspiration. Reported use correlated well with objective use (r = 0.82). Most subjects reported an improvement in their respiratory health (64%) and were satisfied with the device (78%). Higher reported and objective use were associated with increased symptoms (p = 0.001) and higher satisfaction with the device (p = 0.008). We found no association between frequency of use and baseline cough peak flow (CPF), bulbar impairment, non-invasive ventilation use, living environment, or supervised administration.

CONCLUSION:

Regular home MI-E use was associated with greater symptom burden and overall satisfaction with the device and was not influenced by baseline CPF. Patients without substantial bronchorrhea might not use the MI-E regularly but might still need to use the device at home during acute events. Therefore, familiarity with the MI-E via appropriate and repeated practical training is crucial.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Insuflación / Tos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Respiration Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Insuflación / Tos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Respiration Año: 2023 Tipo del documento: Article País de afiliación: Suiza